insights_auto
Bakit tumaas ang 0QF 5.06%?
Tingnan ang Higit pang Detalyechevron_right
0QF:ETR
Moderna Inc
€197.26
arrow_upward
+5.06%(+9.50) 1D
Okt 12, 5:35:39 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 0QF...
Buksan
€202.65
Mataas
€205.25
Mababa
€197.18
Mkt. cap
85.33B
Avg. na dami
28.88K
Dami
49.03K
Mataas nang 52-wk
€205.25
Mababa nang 52-wk
€19.37
Bilang ng mga empleyado
5K
Buksan
€202.65
Mataas
€205.25
Mababa
€197.18
Mkt. cap
85.33B
Avg. na dami
28.88K
Dami
49.03K
Mataas nang 52-wk
€205.25
Mababa nang 52-wk
€19.37
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
1 oras ang nakalipas
Moderna Stock Puts MRNA Cancer Vaccine Shares Back In Focus
AskTraders.com
·
5 oras ang nakalipas
Moderna Shares Drop 5% on Monday
TradingKey
·
6 oras ang nakalipas
Moderna Inc Stock (MRNA) Moved Down by 5.73% on Oct 12: Facts Behind the Movement
Quartz
·
8 oras ang nakalipas
Moderna stock surges more than 600% in 2026
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Tungkol sa Moderna Inc